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A B S T R A C T
This study aimed to identify the characteristics of the vascular network in the superﬁcial subcutaneous layer of
the breast and to analyze diﬀerences between breasts with cancer and contralateral unaﬀected breasts using
vessel branching points (VBPs) detected by three-dimensional photoacoustic imaging with a hemispherical
detector array. In 22 patients with unilateral breast cancer, the average VBP counts to a depth of 7mm below the
skin surface were signiﬁcantly greater in breasts with cancer than in the contralateral unaﬀected breasts
(p < 0.01). The ratio of the VBP count in the breasts with cancer to that in the contralateral breasts was
signiﬁcantly increased in patients with a high histologic grade (p= 0.03), those with estrogen receptor-negative
disease (p < 0.01), and those with highly proliferative disease (p < 0.01). These preliminary ﬁndings indicate
that a higher number of VBPs in the superﬁcial subcutaneous layer of the breast might be a biomarker for
primary breast cancer.
1. Introduction
Ultrasonography (US), mammography, magnetic resonance imaging
(MRI), computed tomography and positron emission tomography are
used to diagnose breast cancer based on the morphology and properties
of the tumor [1]. Features of tumor-associated blood vessels have been
reported not only to be intratumoral such as tumor angiogenesis [2],
but also to include the vascular architecture around the tumor [3,4].
The modalities presently available for imaging of the vasculature in-
clude Doppler US, contrast-enhanced US, and contrast-enhanced MRI
[3,5–9]. However, the contrast agents used can cause allergic reactions
and agents such as gadolinium cannot be used in patients with severe
renal dysfunction. Diﬀuse optical tomography using near-infrared light
can measure the amount of water, fat, and total hemoglobin as well as
its oxygen saturation in tissues [10]. These parameters do not require a
contrast agent and can be measured noninvasively. However, the re-
solution is in the order of centimeters, so it is diﬃcult to discriminate
tumor tissue from normal breast tissue when the tumor is less than a
few centimeters in size. Tumor-related vascular changes in the super-
ﬁcial layer of breasts had not been reported in detail. Photoacoustic
imaging provides good visualization of these superﬁcial areas, and is
able to highlight changes in the superﬁcial vasculature due to tumor.
We have developed a photoacoustic imaging (PAI) system for as-
sessment of blood vessels　[4,11–13]. The third iteration of our pro-
totype system (PAI-03) has high performance to a depth of more than
20mm from the skin surface with submillimeter resolution, allowing
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the structure of ﬁne blood vessels to be visualized [4]. Use of a hemi-
spherical detector array (HDA) and three-dimensional constructed
images provides detailed images of the vascular structures. We have
successfully used the PAI-03 system to detect and analyze blood vessels
associated with cancer.
The PAI system can visualize the vascular network of the breast as
well as the tumor-related vasculature with high resolution. In a pre-
vious study using the PAI-03 system, we identiﬁed certain features of
cancer-associated blood vessels [4]. Adjacent blood vessels oriented
toward the tumor were visualized in patients with invasive breast
cancer, and photoacoustic signals were found to be increased in the
tumor in some cases that had received preoperative chemotherapy.
Tumor angiogenesis results in the formation of immature blood vessels,
which increases the vascular permeability [2]. Increased vascular per-
meability elevates the interstitial pressure and stagnates blood ﬂow,
despite the increase in metabolism and the blood ﬂow requirements
[2,14]. Therefore, we hypothesized that blood volume around the
tumor including the subcutaneous layer might be increased due to the
inﬂuence of increase blood ﬂow requirements on the tumor.
We have been using this system in patients with breast cancer to
evaluate the characteristics of the vascular network in the breast in
detail, including vessel branching points (VBPs) in both the superﬁcial
area just below the skin surface and in the whole breast within the
visual range. In this study, VBPs were deﬁned as the points where blood
vessels divide into two or more branches. We have been attempting to
detect diﬀerences in blood ﬂow between breasts with cancer and con-
tralateral breasts with no detectable cancer using the number of visible
VBPs.
In this report, we present our preliminary data on the relationship
between VBP counts in breasts with cancer and those in contralateral
breasts with no detectable cancer to determine the potential utility of
VBP as a biomarker of primary breast cancer.
2. Material and methods
2.1. Patients
Data of 22 patients with unilateral breast cancer who had partici-
pated in another clinical trial (UMIN00012251) were analyzed in this
study. Patients were enrolled in the clinical trial between December
2014 and December 2015 at Kyoto University Hospital, Japan. The
inclusion criteria for the clinical trial were a primary breast lesion, age
20 years or older at the time of diagnosis, and an Eastern Cooperative
Oncology Group performance status of 0 or 1. The exclusion criteria
included pregnancy, cardiac pacemaker implantation, and any other
condition judged by the clinical investigators to make the patient un-
suitable for inclusion. Patients with benign lesions were also excluded.
The contralateral breasts were diagnosed as cancer-free by mammo-
graphy, US, and MRI. The study was approved by the institutional re-
view board at Kyoto University (UMIN00012251) and was conducted in
accordance with the Helsinki Declaration of 1975, as revised in 2008.
All participants provided written informed consent.
2.2. Conﬁguration of the PAI system
The VBPs were counted using a PAI-03 system with an HDA (Canon
Inc., Tokyo, Japan; in collaboration with Optosonics Inc., Oriental, NC)
[4,15]. The system was modiﬁed by reducing the depth of the breast-
holding cup from 50mm to 38mm. A laser capable of irradiating at
wavelengths of 755 nm and 795 nm was also used. The detector array
was scanned continuously in a spiral pattern in one plane. The spiral
scanning pattern was modiﬁed to gradually increase the density of data
acquisition points as the scan approached the center of the spiral scan.
AQ-switched alexandrite laser with selectable wavelengths of 755 nm
and 795 nm was used. The laser energy used in the PAI-03 system is
approximately 200mJ/pulse and is constant for both wavelengths. The
light illumination was 60mm in diameter at the surface of the breast
cup. The maximum light energy was set to less than 10mJ/cm2, which
is half the maximum permissible exposure recommended by the
American National Standards Institute.
A piezoelectric zirconate titanate transducer was used to detect the
PA signal. The HDA used contains 512 elements on its internal surface,
each within a circle measuring 3mm in diameter. The central frequency
was 2MHz. The imaging area for each laser shot was just within the
range of the 30-mm radius of the cylinder. To enhance the imaging
area, the HDA was scanned spirally in the horizontal plane; this allowed
the imaging area to be selected at radii of 50mm, 70mm, and 100mm.
For each scan data acquisition was set to at either 1024 or 2048 cor-
responding to an acquisition time of 51.2 s and 102.4 s, respectively.
Using a spherical phantom with a diameter of 0.3 mm, the full width at
half maximum was 0.57mm in the x and y directions and 0.37mm in
the z direction.
2.3. Acquisition of PAI data
For each patient, both breasts were scanned in water at body tem-
perature, ﬁrst at a wavelength of 795 nm and then at a wavelength of
755 nm. In each case, a PA image acquired at 795 nm that had equal
oxyhemoglobin and deoxyhemoglobin absorption coeﬃcients and the
image corresponding to the total hemoglobin distribution were used to
analyze the structure of the blood vessels. Hemoglobin oxygen satura-
tion was not analyzed, so the images taken at a wavelength of 755 nm
were not used. PA images were reconstructed using a universal back-
projection algorithm [16], taking into account the average speed of
sound in breast tissue and that in water for impedance matching. The
variations in light ﬂuence in tissue from patient to patient were com-
pensated for by calculating the result of the diﬀusion equation. The PAI
images in this study were constructed using the absorption coeﬃcient
at 795 nm and the color signal intensity.
2.4. Extraction of the breast surface data
A PAI image of the breast in the coronal plane was used to extract
the breast surface. The areas where the skin pigment signal started were
contoured, and the plotted points were obtained manually at intervals
of about 1–2 cm per slice of a 2D image. The same contour extraction
procedure was performed for slices at least every 10 slices (1.25mm) to
obtain a three-dimensional breast contour point group. When the de-
viation between the spline curve based on the original plot points and
the breast shape by skin pigment signal was more than 3mm, the
contour was extracted by adding more plot points. Typically, there were
200–300 plot points per breast. The surface shape of the breast was
reconstructed by approximating these contours as a curved surface. The
moving least squares method [17] was used for surface approximation.
2.5. MRI data acquisition
Breast MRI was performed using a 3.0-T scanner (MAGNETOM Trio,
A Tim System, Siemens AG, Germany) with a dedicated 16-channel
breast array coil. Fat-suppressed T1-weighted dynamic contrast-en-
hanced images were obtained pre-contrast and then at 1–2min (early)
and 5–6min (delayed) after gadolinium injection. Gadoteridol
(ProHance, Eisai Inc., Tokyo, Japan) was power-injected at a dose of
0.2 mL/kg and a speed of 2.0 mL/s, then ﬂushed with 20mL of saline at
the same rate. Whole-breast axial scanning at a high temporal resolu-
tion was performed for 1min (3D-VIBE: TR/TE 3.70/1.36 ms, FA 15
and FOV 330mm×330mm, matrix 384×346, thickness 1.0mm).
Subtraction images were computed pixelwise by subtracting the signal
intensity of the pre-contrast images from that of the early post-contrast
images.
Deformed MRI images were constructed based on pre-contrast and
early post-contrast MRI subtraction images in which blood vessels could
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be observed as with PAI. We manually identiﬁed common features,
such as VBPs or intermediate points between branch and branch in both
modalities, referred to here as “corresponding points”. We then de-
formed the whole breast shape in three dimensions to match each
corresponding point using the thin plate spline method [18].
2.6. Counting methodology
Evaluation was carried out using the signal intensity of PAI images
obtained at a wavelength of 795 nm and deformed MRI subtraction
images. The blood vessels with corresponding points on the MRI image
were deﬁned as "corresponding vessels". VBPs in the PAI image were
deﬁned as the branching points on these corresponding vessels (Fig. 1).
The entire PAI image was deﬁned as the area of interest. Three in-
dependent observers (one was a breast surgeon, and the others were
image processing specialists) manually counted the number of branches
on the corresponding vessels in the three-dimensional image acquired
by PAI. Blood vessel branches other than those of the corresponding
vessels detected on the PAI image were excluded from the analysis. The
branching density values (count per 100 cm2) were calculated after
normalizing the VBPs to the surface area in the region of interest.
2.7. Clinicopathologic characteristics
The patients’ medical records were reviewed to obtain clin-
icopathologic data on age, menopausal status, presence of cardiovas-
cular disease, smoking history, lactation history, hemoglobin status,
body mass index, and systolic blood pressure (BP) at the time of PAI.
Tumor diameter and nodal status were determined based on the pa-
thology reports for the surgical specimens.
After surgery, the excised specimens were sectioned at 5-mm in-
tervals perpendicular to the longest axis of the specimen. The patho-
logic analysis was performed in a conventional manner using formalin-
ﬁxed, paraﬃn-embedded tissues stained with hematoxylin-eosin.
Estrogen and progesterone receptor status in cases of invasive
carcinoma was conﬁrmed by immunohistochemistry. HER2 status was
conﬁrmed by immunohistochemistry or ﬂuorescent in situ hybridiza-
tion. Ki-67 immunostaining was performed using the MIB1 monoclonal
antibody (Dako, Copenhagen, Denmark). Histologic grade was de-
termined by experienced breast pathologists according to the General
Rules for Clinical and Pathological Recoding of Breast Cancer, 15th
edition, based on scores for nuclear pleomorphism, tubule formation,
and mitotic count.
2.8. Statistical analysis
All statistical analyses were performed using JMP 12.2.0 for
Windows (SAS Institute Inc., Cary, NC). The Wilcoxon signed-rank test
was used to detect diﬀerences in VBP counts between breasts with
cancer and the contralateral unaﬀected breasts. The Wilcoxon rank-sum
test was used to determine the relationship between each clin-
icopathologic parameter and the VBP count on each side. A p-
value< 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Patient characteristics and histologic diagnoses
Data for 22 patients with breast cancer were analyzed. The patient
characteristics and the histopathologic characteristics of the breast
cancers are shown in Table 1. Seven patients had cardiovascular dis-
ease, 3 of whom were on antihypertensive treatment with a calcium
channel blocker (n=2) or an angiotensin-converting enzyme inhibitor
(n= 1); both these classes of agents exert their antihypertensive eﬀect
by vasodilation. The breast lesions were diagnosed as ductal carcinoma
in situ (DCIS) in 3 patients and invasive carcinoma in 19 patients.
3.2. Analysis of vessel branching points
Fig. 2 shows a comparison of the VBP counts between MRI and PAI
Fig. 1. (a, d) Number of branching points in a breast with cancer and the contralateral breast with no detectable cancer. Points counted on the PAI image are shown
in red. (b, e) PAI image. (c, f) Color PAI image with deformed MRI. The arrow indicates the site of the cancer. The color bar represents the PAI signal amplitude. Scale
bar, 20mm. MRI, magnetic resonance imaging; PAI, photoacoustic imaging.
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based on the MRI images. The counting area was within a 20-mm radius
of the nipple and to a depth of 5mm. The median number of VBPs was
18 (range, 8–42)/area on PAI and 2 (range, 0–9)/area on MRI. The
diﬀerence was statistically signiﬁcant (p < 0.01, Wilcoxon signed-rank
test).
The distribution of the VBPs is shown in Fig. 3. The focus in this
study was the superﬁcial area, so the analyses were performed for data
to a depth of 7mm below the skin surface, where high-resolution
images of the vascular network could be captured stably for the whole
breast in a measuring cup as described previously [4].
The VBP counts were signiﬁcantly higher in the breasts with cancer
than in the contralateral unaﬀected breasts (p < 0.01, Wilcoxon
signed-rank test; Fig. 4). The median VBP counts were 31.7 (range,
5.87–67.0)/100 cm2 in the breasts with cancer and 27.0 (range,
6.40–44.4)/100 cm2 on the contralateral side. Diﬀerences in the VBP
count between the aﬀected and unaﬀected breasts at depths of 1mm,
3mm, and 5mm, as well as for the whole breast, were all statistically
signiﬁcant (p < 0.01) and remained so after exclusion of the data for
patients on vasodilating antihypertensive drugs.
To identify the factors that increased the ratio of the VBP count on
the aﬀected side to that on the unaﬀected side, we examined the re-
lationship between this ratio and the patient and tumor characteristics.
The VBP count ratio diﬀered signiﬁcantly according to histologic grade,
estrogen receptor status, and Ki-67 positivity (Table 2). In 4 of 19 cases
with invasive breast cancer, the VBP count ratio was less than 1.0; all 4
cases were estrogen receptor-positive and had low Ki-67 values.
There was no signiﬁcant increase in the VBP count on the aﬀected
side in comparison with the unaﬀected side according to nodal status or
whether the disease stage was T1 or T2. There were 3 cases of DCIS, one
of which showed a marked increase in the number of VBPs. In one case,
there was no diﬀerence in the VBP count between the aﬀected and
unaﬀected side, and in the remaining case, the VBP count was higher on
the unaﬀected side.
The VBP counts varied widely from patient to patient. This variation
was investigated in relation to patient and tumor characteristics and
according to the diﬀerence in VBP count between the aﬀected and
unaﬀected sides (Table 3). There was no signiﬁcant diﬀerence in the
VBP count on either side according to age, menopausal status, presence
of cardiovascular disease, smoking history, lactation history, he-
moglobin status, or body mass index. However, the VBP count on the
contralateral side was signiﬁcantly diﬀerent in patients with systolic
BP > 130mmHg compared with those with systolic BP≤ 130mmHg;
this diﬀerence remained when the data were analyzed after exclusion of
patients on antihypertensive agents.
4. Discussion
Few studies have assessed the ﬁne vasculature in the superﬁcial
tissue of the breast. However, a previous study using contrast-enhanced
MRI with gadolinium did not detect any diﬀerence in the VBP count
between patients with benign breast disease and those with breast
cancer [7].
In the present study, more ﬁne vessels were detected by PAI than by
MRI. There was a signiﬁcant diﬀerence in the VBP count between
breasts with cancer and the contralateral breasts, possibly because of an
increase in blood vessel branching and increased blood volume in the
aﬀected breasts. Based on the signals, including those from the super-
ﬁcial layers, it was unlikely that angiogenesis occurred. PAI detects
signals from red blood cells rather than the vessel walls and VBPs were
Table 1
Characteristics of patients and breast cancers.









Mean body mass index (kg/m2) 24.2 (19.8–35.9)
Mean systolic blood pressure 119.2 (92–155)
Mean hemoglobin level (mg/mL) 13.1 (7.0–14.5)

























Median Ki-67 index (%) 15.9
Fig. 2. Number of vascular branching points seen on MRI and PAI. (a) Image from a patient with invasive carcinoma acquired by PAI. Scale bar, 20mm. (b) Image
from the same patient acquired by MRI. Scale bar, 20mm. (c) Comparison of the number of vascular branching points between MRI and PAI based on MRI images.
*p < 0.01 (Wilcoxon signed-rank test), MRI, magnetic resonance imaging; PAI, photoacoustic imaging.
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on linear signals considered to be blood vessels, so a change in the VBP
count could indicate a change in blood dynamics within the vessels. Our
ﬁndings suggest that breasts with cancer may contain a greater volume
of blood than those without cancer.
The VBP count was higher in breasts with cancer if the Ki-67 index
was high and if the cancer had a high histologic grade or was estrogen
receptor-negative. These factors generally predict a high proliferation
rate and poor prognosis [19,20]. Our ﬁndings are consistent with the
concept that a tumor needs a blood supply to be able to proliferate, and
it will be necessary to investigate the relationship between the VBP
count ratio and the prognosis in the future.
The ﬁnding of an increase in the blood volume of the whole breast
on the aﬀected side may reﬂect cancer-related upregulation of local
metabolic activity [21]. In addition, a high interstitial pressure driven
by the tumor may change blood ﬂow around the lesion in terms of not
only speed [22] but also volume and may also have an eﬀect in the
subcutaneous tissues. Multiple factors are expected to be involved in
these changes in blood ﬂow, including energy consumption, interstitial
pressure, and vascular permeability [2,19,21,23]. We found a re-
lationship between VBP count and BP, and events associated with high
BP may include an increased VBP count in the breast.
Compared with the unaﬀected sides, the number of VBP counts in
aﬀected sides increased in both T1 and T2 cases, and the number of VBP
counts also increased in both N negative and N positive cases. the
number of VBP count was higher on the aﬀected side than on the
contralateral side in 1 out of 3 DCIS cases. On the other hand, some
breasts with cancer showed a decrease in the number of VBPs, and all
these cases were estrogen receptor-positive and had low Ki-67 index
values. However, this ﬁnding is diﬃcult to interpret because of the
small number of cases in our study. Further studies in large numbers of
patients are needed to elucidate whether PAI is useful for detection of
early-stage breast cancer and to identify factors that aﬀect the VBP
Fig. 3. Number of vascular branching points according to depth from the skin surface. (☐) Breasts with cancer. (■) Contralateral breasts without cancer. The depth is
the distance from extracted surface on photoacoustic imaging.
Fig. 4. Comparison of the number of vessel branching points in breasts with
cancer and in the contralateral breasts without cancer to a depth of 7mm from
the skin surface. *p < 0.01 (Wilcoxon signed-rank test).
Table 2
Relationship between the ratio of vascular branching points (breast with
cancer/contralateral breast) and clinicopathologic factors.
　 　 N VBP ratio
(median)
p-value
Age, years < 50 10 1.53 0.45
≥50 12 1.27
Menopausal status Premenopausal 12 1.53 0.58
/Perimenopausal
Postmenopausal 10 1.27
Cardiovascular + 7 1.25 0.40
disease – 15 1.42
Antihypertensive
medication
+ 3 1.25 0.77
– 19 1.38
Smoking + 6 1.84 0.06
– 16 1.22
Lactation history + 13 1.30 0.97
– 8 1.45
Unknown 1
Body mass index < 25 16 1.45 0.20
≥25 6 0.99
Systolic blood < 130 15 1.42 0.36
pressure ≥130 7 1.25
Hemoglobin < 13 5 1.64 0.27
(mg/dL) ≥13 17 1.3
Invasion DCIS 3 1.21 1.00
Invasive 19 1.38
carcinoma
Tumor size T1 7 1.51 0.83
≥T2 12 1.10
Nodal metastasis + 7 1.4 0.47
– 12 1.17
Histologic grade 1, 2 11 1.17 0.03*
3 8 1.82
ER + 15 1.25 < 0.01**
– 4 2.04
HER2 + 3 1.97 0.11
– 16 1.27
Ki-67 < 20 14 1.21 < 0.01**
≥20 5 1.97
Wilcoxon rank-sum test, *p < 0.05, **p < 0.01. VBP, vessel branching point.
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count.
In this study, whole-breast VBP counts per 100 cm2 were evaluated
and it was possible to obtain objective counts with high reproducibility.
However, discrimination of arteries and veins on MRI was diﬃcult, so
we did not attempt to distinguish these vessels in the PAI analysis.
There was a time diﬀerence of about 2min between irradiating at one
wavelength and irradiating with the other wavelength. Oxygen sa-
turation could not be calculated accurately because of the slight body
movement that occurs during breathing. It would be interesting to in-
vestigate oxygen saturation in further detail in the future if this problem
can be solved.
We found that the mean VBP count decreased with increasing depth
on both the aﬀected and unaﬀected sides, suggesting that the imaging
capability of PAI may decrease with increasing depth from the skin
surface. Therefore, we opted to use a 7-mm depth from the skin surface
for this study and acquired stable images.
Although more VBPs could be counted with PAI than with MRI, in
this study, only VBPs on the blood vessel seen on MRI among the VBPs
seen on PAI were counted. With the use of PAI images, the number of
counted VBPs depends on the observer and can be aﬀected by artifacts
on PAI images. Therefore, we used MRI as the gold standard in order to
eliminate interobserver diﬀerences.
The VBP count in the breast showed wide interindividual variation.
Other than high systolic BP, we could not identify any parameter in-
ﬂuencing the VBP count in the contralateral unaﬀected breast. The need
for comparison with a contralateral unaﬀected breast when evaluating
the number of VBPs limits the clinical application of this biomarker.
However, future technological advances in PAI will allow the ac-
quisition of more data on ﬁne vascular branching, such that VBP count
can be obtained speciﬁcally for aﬀected breasts without MRI. Due to the
very large numbers and the accuracy of the measurements, an auto-
mated process is necessary. Furthermore, we still need to investigate
interindividual diﬀerences in a larger group of patients and to clarify
the changes in VBP count in relation to age and menopause by obser-
ving individuals over time.
When using the PAI-03 system, a laser with an output of several
hundred millijoules was mounted to obtain a depth performance of at
least 20mm to identify cancer-related blood vessels. The ﬁndings of our
present study suggest that it might be possible to use a weaker laser
power for detection of VBPs in the subcutaneous superﬁcial layer of the
breast. It may also be possible to perform PAI using light-emitting
diodes [24].
Technologic advances in PAI have enabled us to acquire data on ﬁne
vascular branching and obtain VBP counts for the breast. Our pre-
liminary research indicates that the VBP count is higher in breasts with
cancer than in contralateral unaﬀected breasts. Although little is known
about the mechanism involved, further investigations of VBPs using PAI
are warranted to improve our understanding of the role of vascular
networks within the breast, including in breast cancer, and for devel-
opment of new diagnostic tools for primary breast cancer.
5. Conclusion
PAI enabled us to detect ﬁne vascular characteristics, speciﬁcally,
VBPs, in the breast. The VBP count in the subcutaneous superﬁcial layer
of the breast (up to 7mm from the skin surface) appeared to be in-
creased in breasts with cancer when compared with the contralateral
breasts with no detectable cancer. Further research is needed to conﬁrm
these results.
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